I agree that this site is using cookies. You can find further informations here.
X
Pérez-Alonso, Manuel
9454  results:
Search for persons X
?
1

Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 ..:

Álvarez-Abril, Mari Carmen ; García-Alcover, Irma ; Colonques-Bellmunt, Jordi...
International Journal of Molecular Sciences.  24 (2023)  12 - p. 9820 , 2023
Link: https://doi.org/10.3390/..
 
?
2

BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation ..:

Overby, Sarah J. ; Cerro-Herreros, Estefanía ; Espinosa-Espinosa, Jorge...
Pharmaceutics.  15 (2023)  4 - p. 1118 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Proof of concept of peptide-linked blockmiR-induced MBNL fu..:

Overby, Sarah J. ; Cerro-Herreros, Estefanía ; González-Martínez, Irene...
Molecular Therapy - Nucleic Acids.  27 (2022)  - p. 1146-1155 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Design of novel small molecule base-pair recognizers of tox..:

Ondono, Raul ; Lirio, Ángel ; Elvira, Carlos...
Computational and Structural Biotechnology Journal.  19 (2021)  - p. 51-61 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Defined d-hexapeptides bind CUG repeats and rescue phenotyp..:

Rapisarda, Anna ; Bargiela, Ariadna ; Llamusi, Beatriz...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
6

Preclinical characterization of antagomiR-218 as a potentia..:

Cerro-Herreros, Estefanía ; González-Martínez, Irene ; Moreno, Nerea...
Molecular Therapy - Nucleic Acids.  26 (2021)  - p. 174-191 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Therapeutic Potential of AntagomiR-23b for Treating Myotoni..:

Cerro-Herreros, Estefanía ; González-Martínez, Irene ; Moreno-Cervera, Nerea...
Molecular Therapy - Nucleic Acids.  21 (2020)  - p. 837-849 , 2020
Link: https://doi.org/10.1016/..
 
?
8

miR-23b and miR-218 silencing increase Muscleblind-like exp..:

Cerro-Herreros, Estefania ; Sabater-Arcis, Maria ; Fernandez-Costa, Juan M....
Nature Communications.  9 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
9

In silico discovery of substituted pyrido[2,3-d]pyrimidines..:

González, Àlex L. ; Konieczny, Piotr ; Llamusi, Beatriz...
PLOS ONE.  12 (2017)  6 - p. e0178931 , 2017
Link: https://doi.org/10.1371/..
 
?
10

Myotonic dystrophy: candidate small molecule therapeutics:

Konieczny, Piotr ; Selma-Soriano, Estela ; Rapisarda, Anna S....
Drug Discovery Today.  22 (2017)  11 - p. 1740-1748 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Expanded CCUG repeat RNA expression in Drosophila heart and..:

Cerro-Herreros, Estefania ; Chakraborty, Mouli ; Pérez-Alonso, Manuel..
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
12

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Typ..:

Fernandez-Costa, Juan M. ; Llamusi, Beatriz ; Bargiela, Ariadna...
PLOS ONE.  11 (2016)  2 - p. e0150501 , 2016
Link: https://doi.org/10.1371/..
 
?
13

Pentamidine rescues contractility and rhythmicity in a Dros..:

Chakraborty, Mouli ; Selma-Soriano, Estela ; Magny, Emile...
Disease Models & Mechanisms.  , 2015
Link: https://doi.org/10.1242/..
 
?
14

Development of aDrosophila melanogasterspliceosensor system..:

García-Alcover, Irma ; Colonques-Bellmunt, Jordi ; Garijo, Raquel...
Disease Models & Mechanisms.  , 2014
Link: https://doi.org/10.1242/..
 
?
15

In vivo strategies for drug discovery in myotonic dystrophy..:

Garcia-Alcover, Irma ; Castel, Arturo López ; Perez-Alonso, Manuel.
Drug Discovery Today: Technologies.  10 (2013)  1 - p. e97-e102 , 2013
Link: https://doi.org/10.1016/..
 
1-15